SCHEMBL5063241

SCHEMBL5063241

CC[C@H]1NC(=O)c2ccccc2NC1=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGAT2 Q10469 1/20 0.56
PDGFRA P16234 1/20 0.47
FER P16591 1/20 0.47
LTK P29376 1/20 0.47
CDK8 P49336 1/20 0.47
ACVR1 Q04771 1/20 0.47
LRRK2 Q5S007 1/20 0.47
DYRK1B Q9Y463 1/20 0.47
TNKS2 Q9H2K2 7/20 0.45
PBRM1 Q86U86 1/20 0.44
CREBBP Q92793 2/20 0.43
BRPF1 P55201 1/20 0.43
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43
TNKS O95271 2/20 0.42
PARP3 Q9Y6F1 2/20 0.42
GFER P55789 1/20 0.41
CYP1A2 P05177 1/20 0.41
KDM4E B2RXH2 4/20 0.41
ALDH1A1 P00352 4/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8267141 0.83 PDGFRA (0.47) MGAT2PDGFRAFERLTKCDK8
SCHEMBL5586294 0.83 TNKS2 (0.46) MGAT2PDGFRAFERLTKCDK8
SCHEMBL5586295 0.83 TNKS2 (0.46) MGAT2PDGFRAFERLTKCDK8
SCHEMBL30418670 0.82 CREBBP (0.58) CREBBPBRPF1KDM4EALDH1A1HPGD
SCHEMBL11445118 0.82 CREBBP (0.58) CREBBPBRPF1KDM4EALDH1A1HPGD
SCHEMBL8871785 0.81 GFER (0.52) MGAT2PDGFRAFERLTKCDK8
SCHEMBL8871789 0.81 GFER (0.52) MGAT2PDGFRAFERLTKCDK8
SCHEMBL9054730 0.81 GFER (0.52) MGAT2PDGFRAFERLTKCDK8
SCHEMBL17444761 0.80 ALDH1A1 (0.55) PDGFRAFERLTKCDK8ACVR1
SCHEMBL14454673 0.80 ALDH1A1 (0.55) PDGFRAFERLTKCDK8ACVR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080161294-A1 Urea derivative, medicinal composition containing the same, and medicinal use of these KISSEI PHARMACEUTICAL CO., LTD. (JP) 2008-07-03 US disclosed
EP-1867639-A1 UREA DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND MEDICINAL USE OF THESE Kissei Pharmaceutical Co., Ltd. (JP) 2007-12-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161294-A1 Urea derivative, medicinal composition containing the same, and medicinal use of these AVPR2, UTS2R, GPR119 MGAT2 2684/4885PDGFRA 2249/4885FER 3237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.